Free Trial
LON:TGP

Tekmar Group (TGP) Share Price, News & Analysis

GBX 6.50 +0.25 (+4.00%)
As of 08:00 AM Eastern

About Tekmar Group Stock (LON:TGP)

Key Stats

Today's Range
6.25
6.50
50-Day Range
4.50
6.29
52-Week Range
4
10.20
Volume
217,987 shs
Average Volume
257,858 shs
Market Capitalization
£8.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TGP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekmar Group and its competitors with MarketBeat's FREE daily newsletter.

TGP Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
River Global Increases Stake in Tekmar Group
Tekmar Group Sees Adjustments in Major Shareholdings
See More Headlines

TGP Stock Analysis - Frequently Asked Questions

Tekmar Group's stock was trading at GBX 6 at the beginning of the year. Since then, TGP shares have increased by 8.3% and is now trading at GBX 6.50.

Tekmar Group plc (LON:TGP) posted its quarterly earnings results on Thursday, June, 26th. The company reported ($1.50) EPS for the quarter. Tekmar Group had a negative net margin of 23.74% and a negative trailing twelve-month return on equity of 53.81%.

Shares of TGP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tekmar Group investors own include Recursion Pharmaceuticals (RXRX), CRISPR Therapeutics (CRSP), Newmont (NEM), ADMA Biologics (ADMA), Butterfly Network (BFLY), DarioHealth (DRIO) and Fortress Biotech (FBIO).

Company Calendar

Last Earnings
6/26/2025
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Engineering & Construction
Sub-Industry
N/A
Current Symbol
LON:TGP
CIK
N/A
Fax
N/A
Employees
172
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (3.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£4.29 million
Net Margins
-23.74%
Pretax Margin
N/A
Return on Equity
-53.81%
Return on Assets
-9.26%

Debt

Debt-to-Equity Ratio
21.65
Current Ratio
1.59
Quick Ratio
1.70

Sales & Book Value

Annual Sales
£18.08 million
Price / Sales
0.47
Cash Flow
GBX 15.85 per share
Price / Cash Flow
0.41
Book Value
GBX 12.13 per share
Price / Book
0.53

Miscellaneous

Outstanding Shares
131,545,662
Free Float
N/A
Market Cap
£8.52 million
Optionable
Not Optionable
Beta
2.06
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:TGP) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners